Literature DB >> 26813515

Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case-Control Study.

F López-Medrano1, J T Silva1, M Fernández-Ruiz1, P L Carver2, C van Delden3, E Merino4, M J Pérez-Saez5, M Montero6, J Coussement7, M de Abreu Mazzolin8, C Cervera9, L Santos10, N Sabé11, A Scemla12, E Cordero13, L Cruzado-Vega14, P L Martín-Moreno15, Ó Len16, E Rudas17, A Ponce de León18, M Arriola19, R Lauzurica20, M David21, C González-Rico22, F Henríquez-Palop23, J Fortún24, M Nucci25, O Manuel26, J R Paño-Pardo27, M Montejo28, P Muñoz29, B Sánchez-Sobrino30, A Mazuecos31, J Pascual5, J P Horcajada6, T Lecompte3, C Lumbreras1, A Moreno9, J Carratalà11, M Blanes32, D Hernández17, E A Hernández-Méndez18, M C Fariñas22, M Perelló-Carrascosa33, J M Morales34, A Andrés34, J M Aguado1.   

Abstract

Risk factors for invasive pulmonary aspergillosis (IPA) after kidney transplantation have been poorly explored. We performed a multinational case-control study that included 51 kidney transplant (KT) recipients diagnosed with early (first 180 posttransplant days) IPA at 19 institutions between 2000 and 2013. Control recipients were matched (1:1 ratio) by center and date of transplantation. Overall mortality among cases was 60.8%, and 25.0% of living recipients experienced graft loss. Pretransplant diagnosis of chronic pulmonary obstructive disease (COPD; odds ratio [OR]: 9.96; 95% confidence interval [CI]: 1.09-90.58; p = 0.041) and delayed graft function (OR: 3.40; 95% CI: 1.08-10.73; p = 0.037) were identified as independent risk factors for IPA among those variables already available in the immediate peritransplant period. The development of bloodstream infection (OR: 18.76; 95% CI: 1.04-339.37; p = 0.047) and acute graft rejection (OR: 40.73, 95% CI: 3.63-456.98; p = 0.003) within the 3 mo prior to the diagnosis of IPA acted as risk factors during the subsequent period. In conclusion, pretransplant COPD, impaired graft function and the occurrence of serious posttransplant infections may be useful to identify KT recipients at the highest risk of early IPA. Future studies should explore the potential benefit of antimold prophylaxis in this group. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; epidemiology; fungal; infection and infectious agents; infectious disease; kidney transplantation/nephrology

Mesh:

Year:  2016        PMID: 26813515     DOI: 10.1111/ajt.13735

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

1.  Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.

Authors:  Wei Zhou; Hongxing Li; Yan Zhang; Mei Huang; Qian He; Pei Li; Fang Zhang; Yi Shi; Xin Su
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  The 'hole' story of a lung: Answers.

Authors:  Aadil Kakajiwala; Priyanka Fernandes; Bruce R Pawel; Sandra Amaral
Journal:  Pediatr Nephrol       Date:  2016-07-18       Impact factor: 3.714

3.  Risk factors for development and mortality of invasive pulmonary Aspergillosis in kidney transplantation recipients.

Authors:  Hyeri Seok; Kyungmin Huh; Sun Young Cho; Cheol-In Kang; Doo Ryeon Chung; Woo Seong Huh; Jae Berm Park; Kyong Ran Peck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-11       Impact factor: 3.267

Review 4.  Does Post-Transplant Cytomegalovirus Increase the Risk of Invasive Aspergillosis in Solid Organ Transplant Recipients? A Systematic Review and Meta-Analysis.

Authors:  Nipat Chuleerarux; Achitpol Thongkam; Kasama Manothummetha; Saman Nematollahi; Veronica Dioverti-Prono; Pattama Torvorapanit; Nattapong Langsiri; Navaporn Worasilchai; Rongpong Plongla; Ariya Chindamporn; Anawin Sanguankeo; Nitipong Permpalung
Journal:  J Fungi (Basel)       Date:  2021-04-23

5.  Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients.

Authors:  Zi-Wei Li; Feng-Hua Peng; Miao Yan; Wu Liang; Xiao-Lei Liu; Yan-Qin Wu; Xiao-Bin Lin; Sheng-Lan Tan; Feng Wang; Ping Xu; Ping-Fei Fang; Yi-Ping Liu; Da-Xiong Xiang; Bi-Kui Zhang
Journal:  Ther Drug Monit       Date:  2017-08       Impact factor: 3.681

6.  Monitoring of clinical strains and environmental fungal aerocontamination to prevent invasive aspergillosis infections in hospital during large deconstruction work: a protocol study.

Authors:  Sophie Tiphaine Loeffert; Elise Melloul; Cédric Dananché; Laetitia Hénaff; Thomas Bénet; Pierre Cassier; Damien Dupont; Jacques Guillot; Françoise Botterel; Martine Wallon; Marie-Paule Gustin; Philippe Vanhems
Journal:  BMJ Open       Date:  2017-11-25       Impact factor: 2.692

7.  And then there were none.

Authors:  J Tiago Silva; C Mejía-Chew; A Spec; J M Aguado; F López-Medrano
Journal:  Rev Esp Quimioter       Date:  2019-11-18       Impact factor: 1.553

8.  Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.

Authors:  Dionysios Neofytos; Carolina Garcia-Vidal; Frédéric Lamoth; Christoph Lichtenstern; Alessandro Perrella; Jörg Janne Vehreschild
Journal:  BMC Infect Dis       Date:  2021-03-24       Impact factor: 3.090

9.  Update in Infectious Diseases 2018.

Authors:  F J Candel; T Emilov; I Diaz de la Torre; A Ruedas; J M Viñuela Prieto; C Visiedo; J Martínez-Jordán; L López-González; M Matesanz; A Arribi
Journal:  Rev Esp Quimioter       Date:  2018-09       Impact factor: 1.553

10.  Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients.

Authors:  Yi-Chang Zhao; Xiao-Bin Lin; Bi-Kui Zhang; Yi-Wen Xiao; Ping Xu; Feng Wang; Da-Xiong Xiang; Xu-Biao Xie; Feng-Hua Peng; Miao Yan
Journal:  Clin Transl Sci       Date:  2020-11-30       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.